How do you pay?

How to pay the least

Cash price

$4,090+ for 30 tablets

Pharmacies pay about this for Biktarvy; you’d pay more.

  1. Ask your pharmacy for Biktarvy’s cash price, and one or two other pharmacies too.
  2. Biktarvy’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Advancing Access Patient Assistance Program/Medication Assistance Program (PAP/MAP). Or call 1-800-226-2056.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameBiktarvy
Authorized genericbictegravir, emtricitabine, and tenofovir alafenamide
Regular genericbictegravir, emtricitabine, and tenofovir alafenamide
What you’d pay
At least$4,090for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Biktarvy?
The original
–
–

Brand nameThe maker’s card

Gilead Advancing Access Co-pay Savings Program

Savings card from Gilead Sciences

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a month

The card takes up to $7,200 a year off your co-pay.

Sign up on biktarvyhcp.com 

Or call 1-800-226-2056.

In the maker’s words

“Eligible, commercially insured individuals enrolled in Gilead Advancing Access co-pay coupon card program could pay as little as $0.”

From the maker’s offer on biktarvyhcp.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Biktarvy itself, from the same company, sold without the brand name, and usually for less. For now Biktarvy is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

BIKTARVY is a three-drug combination of bictegravir (BIC), a human immunodeficiency virus type 1 (HIV-1) integrase strand transfer inhibitor (INSTI), and emtricitabine (FTC) and tenofovir alafenamide (TAF), both HIV-1 nucleoside analog reverse transcriptase inhibitors (NRTIs), and is indicated as a complete regimen for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 14 kg:

  • with no antiretroviral treatment history or
  • with an antiretroviral treatment history and not virologically suppressed, with no known or suspected substitutions associated with resistance to the integrase strand inhibitor class, emtricitabine, or tenofovir, or
  • to replace the current antiretroviral regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per mL) on a stable antiretroviral regimen with no known or suspected substitutions associated with resistance to bictegravir or tenofovir.

Source: the FDA label for Biktarvy (Gilead Sciences, Inc.), September 9, 2026. Full label on DailyMed 

Good to know